A lack of inforcement has given an opening to drugmakers to restrict access to drugs discounted under the 340B program. Many acute sites of care are requesting the Department of Health and Human Services (HHS) get involved to push back on drug companies, including Novartis…
Covid 19 restrictions continue in many hot spot cities, but 14 states have begun lifting their restrictions as a very difficult April came to a close. These changes provide new challenges for us all, but for those in healthcare it means reopening of non-critical care…
With the surge of COVID 19 patients, key medications are now included in the shortages of critical concern for treating patients. Antibiotics, antivirals and sedatives to treat patients requiring ventilators, are at the top of the shortage list, but there are also concerns on other…
With so many medical supply companies based in China and with the increase in the need of preventative care supplies, companies are now looking at the implications of the virus spread on needed supplies. Many are stocking up to ensure they can meet demand, while…